News
Beta-blockers are one of the most widely prescribed classes of drugs to treat hypertension (high blood pressure) and are a mainstay treatment of congestive heart failure.Beta-blockers work by ...
A new beta blocker marketed as Bystolic (generic name, nebivolol) is available that may be the answer for many patients suffering from heart arrhythmia and hypertension.
Beta-blockers slow the electrical signals in your heart and slow down your heart rate and its ability to pump blood, so it’s important to follow your doctor’s instructions carefully.
Hosted on MSN5mon
What is a beta blocker? Why they are vital to those with various heart diseases - MSNOne way or another, beta blockers are always in the news. Take, for instance, Los Angeles Chargers Head Coach Jim Harbaugh, who revealed in October that he's part of a growing group of Americans ...
Beta blocker antagonizes another neurohormone in the body called norepinephrine, which is related to the hyperactivity of the sympathetic nervous system. And like the other neurohormones like ...
"Yeah, yeah, I took a beta blocker so this will be a breeze," Robert Downey Jr. said when he took the stage. Here's everything you need to know.
Beta-blocker treatment did not appear to lead to a lower cumulative incidence of the secondary end points (death from any cause, 3.9% in the beta-blocker group and 4.1% in the no–beta-blocker ...
Hosted on MSN10mon
Is long-term beta-blocker therapy needed after a heart attack? - MSNThe cardiovascular safety of an interrupting beta-blocker could not be shown in comparison to continuation in patients with a history of myocardial infarction (MI) and there was no benefit to the ...
One way or another, beta blockers are always in the news. Take, for instance, Los Angeles Chargers Head Coach Jim Harbaugh, who revealed in October that he's part of a growing group of Americans ...
Researchers also assessed 149 beta-blocker users with mmHD (mean age, 59 years; 58% men) who were matched with 149 nonusers (mean age, 59 years; 61% men).
In patients who had revascularization after an acute MI and had a preserved EF, long-term beta-blocker use showed no benefit compared with no beta-blockers, in REDUCE-AMI.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results